Skip to content

BD Max™ GBS 441772

by Becton, Dickinson and Company

Ref 441772

BD Max GBS 441772 is an in vitro diagnostic device (EU IVDR Class C; FDA Class I; EMDN category strep. b detection by na reagents) made by Becton, Dickinson and Company, registered in EUDAMED on 22 Sep 2026 (Basic UDI-DI 038290HDRXTDUXEX), cleared under FDA 510(k) K111860 on 16 Feb 2012 and listed in FDA GUDID since 19 May 2016 (UDI-DI 00382904417727), active as of 26 Oct 2026. 4 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K111860

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 26 Oct 2026.

Regulatory status

as of registry sync 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number038290HDRXTDUXEX Basic UDI-DI 00382904417727UDI-DIDate22 Sep 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00382904417727 UDI-DI Date19 May 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK111860 Date16 Feb 2012DecidedStatusActive

Official records

From the FDA record

Device description
BD MAX™ GBS
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 26 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 038290HDRXTDUXEX registered 22 Sep 2026 Active
  • FDA 510(k) K111860 decided 16 Feb 2012 Active
  • FDA GUDID UDI-DI 00382904417727 listed 19 May 2016 Listed

Recalls

7 recalls · 3 ongoing · FDA

    • Ongoing Z-0238-2026 FDA Class II initiated 23 Sep 2025 on shared 510(k) K111860

    Product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.

    • Ongoing Z-1004-2025 FDA Class II initiated 19 Dec 2024

    Potential for signal drift in specific lots of BD PCR Cartridges.

    • Ongoing Z-0590-2025 FDA Class II initiated 31 Oct 2024 on shared 510(k) K111860

    BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.

    • Terminated Z-1864-2017 FDA Class II initiated 29 Jul 2015 on shared 510(k) K111860

    The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers utilizing only IVD assays are not affected. This anomaly may cause the OSR customer system to incorrectly switch the columns of the truth table on the users display. If the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting. BD is able to trace the issue to a limited number of instruments that have software version 4.44A installed. Note that the problem only affects customers that are either creating a new UDP with Result Logic or modifying the Result Logic of an existing UDP.

    • Terminated Z-1662-2013 FDA Class III initiated 31 May 2013

    Electrical power module installed on some in vitro diagnostic instruments does not meet industry standards as labeled.

    • Terminated Z-0976-2013 FDA Class II initiated 11 Dec 2012

    Cartridges are not sealing properly during PCR testing and may cause false results, indeterminates and/or invalid runs.

    • Terminated Z-0701-2013 FDA Class II initiated 18 Sep 2012

    Clinical diagnostic instrument may exhibit minor defects, which could lead to erroneous test results.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

10 dated events

  1. Cleared FDA 510(k) K111860
  2. Recall initiated FDA recalls Z-0701-2013
  3. Recall initiated FDA recalls Z-0976-2013
  4. Recall initiated FDA recalls Z-1662-2013
  5. Recall initiated FDA recalls Z-1864-2017
  6. Listed FDA GUDID 00382904417727
  7. Recall initiated FDA recalls Z-0590-2025
  8. Recall initiated FDA recalls Z-1004-2025
  9. Recall initiated FDA recalls Z-0238-2026
  10. Registered EUDAMED 038290HDRXTDUXEX

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Max EUDAMED
Bd Max™ Gbs GUDID
Generic name
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
441772
Primary DI / UDI-DI
00382904417727
Basic UDI-DI
038290HDRXTDUXEX
510(k) Number
FDA product code
NJR, OOI
EMDN code
W0105011104 Strep. b detection by na reagents
GMDN term
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class C EUDAMED
Class I GUDID
Regulation number
866.3740, 862.2570
EU registration type
Standard device
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class C
GUDID
Class I

Device class is stated on each registry's own scale: Class C in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under STREP. B DETECTION BY NA REAGENTS.

Other devices from Becton, Dickinson and Company

See all devices from Becton, Dickinson and Company →

Properties

  • Single use
  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (16, all answered No)